Liver, Cardiovascular and Infectious Outcomes in Alcohol‐Associated Liver Disease With Cardiometabolic Risk Factors

Key Points

• This research aims to evaluate the impact of cardiometabolic risk factors on outcomes in alcohol-associated liver disease.
• Analyzed the relationship between cardiometabolic risk factors and outcomes in individuals with alcohol-associated liver disease.
• Assessed short- to intermediate-term mortality rates.
• Examined the incidence of liver, cardiovascular, and infectious morbidity.
• Cardiometabolic risk factors do not increase mortality in alcohol-associated liver disease.
• Identified a phenotype associated with significantly higher morbidity.
• Recommended integration of systematic detection and management into care pathways for alcohol-associated liver disease.